BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31752667)

  • 1. A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas.
    Li X; Shi G; Chu Q; Jiang W; Liu Y; Zhang S; Zhang Z; Wei Z; He F; Guo Z; Qi L
    BMC Genomics; 2019 Nov; 20(1):881. PubMed ID: 31752667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors.
    Zhang J; Deng J; Feng X; Tan Y; Li X; Liu Y; Li M; Qi H; Tang L; Meng Q; Yan H; Qi L
    Front Genet; 2022; 13():944167. PubMed ID: 36105102
    [No Abstract]   [Full Text] [Related]  

  • 3. A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.
    Karlsson A; Cirenajwis H; Ericson-Lindquist K; Brunnström H; Reuterswärd C; Jönsson M; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Micke P; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
    Sci Rep; 2019 Mar; 9(1):5207. PubMed ID: 30914778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of AGR2 and KRT5 as an immunomarker combination in distinguishing lung squamous cell carcinoma from adenocarcinoma.
    Pan B; Wei ZX; Zhang JX; Li X; Meng QW; Cao YY; Qi LS; Yu Y
    Am J Transl Res; 2021; 13(5):4464-4476. PubMed ID: 34150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
    Girard L; Rodriguez-Canales J; Behrens C; Thompson DM; Botros IW; Tang H; Xie Y; Rekhtman N; Travis WD; Wistuba II; Minna JD; Gazdar AF
    Clin Cancer Res; 2016 Oct; 22(19):4880-4889. PubMed ID: 27354471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
    Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
    Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas.
    Koh YW; Lee D; Lee SJ
    Medicine (Baltimore); 2019 Mar; 98(11):e14876. PubMed ID: 30882693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overexpression of OLC1 in Lung Squamous Cell Carcinoma Tissues is Associated with Poor Prognosis of Patients].
    Zhang K; Zhao G; Xiao T; Li P; Song J; Gao Y; Sun K
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):346-351. PubMed ID: 28532543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
    Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
    Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.
    Yuan F; Lu L; Zou Q
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165822. PubMed ID: 32360590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
    Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
    Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch.
    Yang JW; Song DH; An HJ; Seo SB
    Sci Rep; 2022 Feb; 12(1):1830. PubMed ID: 35115593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
    Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes.
    Sellers K; Allen TD; Bousamra M; Tan J; Méndez-Lucas A; Lin W; Bah N; Chernyavskaya Y; MacRae JI; Higashi RM; Lane AN; Fan TW; Yuneva MO
    Br J Cancer; 2019 Jul; 121(1):51-64. PubMed ID: 31114017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected Samples.
    Koper A; Zeef LA; Joseph L; Kerr K; Gosney J; Lindsay MA; Booton R
    Respir Res; 2017 Jan; 18(1):12. PubMed ID: 28073359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
    Pu RT; Pang Y; Michael CW
    Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.